Back to Search
Start Over
Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™
- Source :
- Financial Services Monitor Worldwide. August 1, 2024
- Publication Year :
- 2024
-
Abstract
- (GlobeNewswire) - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today provided an update on [...]
- Subjects :
- United States. Food and Drug Administration
Fibromyalgia
Cyclobenzaprine
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Financial Services Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.803402837